Stay updated with breaking news from Romain didier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lower Post-TAVR Mortality Seen on DOAC vs VKA When OAC Indicated medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
DOACs May Have Advantage Over VKAs After TAVI, Study Hints tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.
Vancouver, British Columbia and Minneapolis, Minnesota (Newsfile Corp. - May 13, 2021) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN) today announced that it will sponsor a symposium ....
Neovasc Inc.: Neovasc Announces First Neovasc Reducer Implants in France Vancouver, British Columbia and Minneapolis, Minnesota (Newsfile Corp. - December 15, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ( Neovasc or the Company ) announced today that it has completed the first three Neovasc Reducer ( Reducer ) implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina. The implants were conducted by Prof. Martine Gilard, Director of Interventional Cardiology, and Prof. Romain Didier, Brest University Hospital, France. Prof. Stefan Verheye, Interventional Cardiologist at the Antwerp Cardiovascular Center in Middelheim, Belgium, provided support for the procedures. Refractory angina is a difficult burden for many French patients despite medical therapy or invasive procedures, said Prof. Gilard. I m gratified that we were able to offer the Reducer treatm ....
Share: VANCOUVER and MINNEAPOLIS, Dec. 15, 2020 (GLOBE NEWSWIRE) via NewMediaWire Neovasc Inc. ( Neovasc or the Company ) (NASDAQ, TSX: NVCN) announced today that it has completed the first three Neovasc Reducer™ ( Reducer ) implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina. The implants were conducted by Prof. Martine Gilard, Director of Interventional Cardiology, and Prof. Romain Didier, Brest University Hospital, France. Prof. Stefan Verheye, Interventional Cardiologist at the Antwerp Cardiovascular Center in Middelheim, Belgium, provided support for the procedures. Refractory angina is a difficult burden for many French patients despite medical therapy or invasive procedures, said Prof. Gilard. I m gratified that we were able to offer the Reducer treatment for the first time in France. ....